- Home
- WKEY vs GALT Comparison
WKEY vs GALT Comparison
Compare WKEY & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WKEY
- GALT
- Stock Information
- Founded
- WKEY 1999
- GALT 2000
- Country
- WKEY Switzerland
- GALT United States
- Employees
- WKEY N/A
- GALT N/A
- Industry
- WKEY EDP Services
- GALT Biotechnology: Pharmaceutical Preparations
- Sector
- WKEY Technology
- GALT Health Care
- Exchange
- WKEY Nasdaq
- GALT Nasdaq
- Market Cap
- WKEY 78.1M
- GALT 83.5M
- IPO Year
- WKEY N/A
- GALT N/A
- Fundamental
- Price
- WKEY $6.41
- GALT $1.37
- Analyst Decision
- WKEY Strong Buy
- GALT Hold
- Analyst Count
- WKEY 1
- GALT 1
- Target Price
- WKEY $4.00
- GALT N/A
- AVG Volume (30 Days)
- WKEY 245.2K
- GALT 166.6K
- Earning Date
- WKEY 06-24-2025
- GALT 08-12-2025
- Dividend Yield
- WKEY N/A
- GALT N/A
- EPS Growth
- WKEY N/A
- GALT N/A
- EPS
- WKEY N/A
- GALT N/A
- Revenue
- WKEY $11,875,000.00
- GALT N/A
- Revenue This Year
- WKEY $18.18
- GALT N/A
- Revenue Next Year
- WKEY $112.51
- GALT N/A
- P/E Ratio
- WKEY N/A
- GALT N/A
- Revenue Growth
- WKEY N/A
- GALT N/A
- 52 Week Low
- WKEY $1.61
- GALT $0.73
- 52 Week High
- WKEY $14.00
- GALT $3.17
- Technical
- Relative Strength Index (RSI)
- WKEY 52.16
- GALT 55.58
- Support Level
- WKEY $6.12
- GALT $1.28
- Resistance Level
- WKEY $8.11
- GALT $1.36
- Average True Range (ATR)
- WKEY 0.61
- GALT 0.07
- MACD
- WKEY -0.08
- GALT 0.01
- Stochastic Oscillator
- WKEY 24.44
- GALT 88.24
About WKEY WISeKey International Holding Ltd
WISeKey International Holding Ltd is a cybersecurity company focused on delivering integrated security solutions for the Internet of Things and digital identity ecosystems. It integrates secure semiconductors, cybersecurity software, and a globally recognized Root of Trust (RoT) into products and services that protect users, devices, data and transactions in the internet-connected world. It has two business segments. The IoT segment, which is the key revenue driver, generates revenue from the sale of semiconductor's secure chips. The mPKI segment generates revenues from Digital Certificates, It derives maximum revenue from IoT segment.
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.